Galaxy Medicare

GMLMedical Equipment & Supplies
17.90+0.00 (+0.00%)
As on 30 Jan 2026, 01:39 pmMarket Closed

Fundamental Score

...

Galaxy Medicare Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

14.46%
Good

Return on Capital Employed

17.72%

Operating Profit Margin (5Y)

N/A
Poor

Dividend Yield

0.00%

Valuation Metrics

Excellent

Price to Earnings

8.56x

Market Capitalization

28.15 (Cr)

Industry P/E

47.87x

Growth Metrics

YoY Quarterly Profit Growth

N/A

YoY Quarterly Sales Growth

N/A

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Excellent

Debt to Equity

0.19x
Excellent

Interest Coverage

6.97x

Free Cash Flow (5Y)

N/A

Ownership Structure

Good

Promoter Holding

72.43%
Poor

FII Holding

0.00%
Poor

DII Holding

1.85%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
72.43%
Promoter Holding
28.15 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of GML across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Excellent ROCE Performance (17.72%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Attractive Valuation (P/E: 8.56 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Conservative Debt Levels (D/E: 0.19)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (6.97x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (72.43%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Limited Institutional Interest (FII+DII: 1.85%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Galaxy Medicare

About GML

Company Details

Symbol:GML
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies
Website:N/A

GML Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)14.46%
Return on Capital Employed17.72%
Operating Profit Margin (5Y)N/A%
Debt to Equity Ratio0.19
Interest Coverage Ratio6.97

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit GrowthN/A%
YoY Quarterly Sales GrowthN/A%

Frequently Asked Questions

What is the current price of Galaxy Medicare (GML)?

As of 30 Jan 2026, 01:39 pm IST, Galaxy Medicare (GML) is currently trading at ₹17.90. The stock has a market capitalization of ₹28.15 (Cr).

Is GML share price Overvalued or Undervalued?

GML is currently trading at a P/E ratio of 8.56x, compared to the industry average of 47.87x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Galaxy Medicare share price?

Key factors influencing GML's price include its quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Galaxy Medicare a good stock for long-term investment?

Galaxy Medicare shows a 5-year Profit Growth of N/A% and an ROE of 14.46%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.19 before investing.

How does Galaxy Medicare compare with its industry peers?

Galaxy Medicare competes with major peers in the Medical Equipment & Supplies. Investors should compare GML's P/E of 8.56x and ROE of 14.46% against the industry averages to determine its competitive standing.

What is the P/E ratio of GML and what does it mean?

GML has a P/E ratio of 8.56x compared to the industry average of 47.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹9 for every ₹1 of annual earnings.

How is GML performing according to Bull Run's analysis?

GML has a Bull Run fundamental score of 27.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does GML belong to?

GML operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Galaxy Medicare.

What is Return on Equity (ROE) and why is it important for GML?

GML has an ROE of 14.46%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Galaxy Medicare generates profits from shareholders' equity.

How is GML's debt-to-equity ratio and what does it indicate?

GML has a debt-to-equity ratio of 0.19, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is GML's dividend yield and is it a good dividend stock?

GML offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has GML grown over the past 5 years?

GML has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in GML and why does it matter?

Promoters hold 72.43% of GML shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is GML's market capitalization category?

GML has a market capitalization of ₹28 crores, placing it in the Small-cap category.

How volatile is GML stock?

GML has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for GML?

GML has a 52-week high of ₹N/A and low of ₹N/A.

What is GML's operating profit margin trend?

GML has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.

How is GML's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.

What is the institutional holding pattern in GML?

GML has FII holding of 0.00% and DII holding of 1.85%. Significant institutional holding often suggests professional confidence in the stock.